TrialJournal of clinical hypertension (Greenwich, Conn.)2007

The efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk.

Matthew R Weir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.